FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

In a surprise post this afternoon, new FDA Commissioner Dr Martin Makary announced a completed pilot at the FDA of a generative AI-based system for speeding up drug review - and plans to roll out ...

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT ...

The U.S. Food and Drug Administration said on Thursday all its centers will deploy artificial intelligence internally ...

The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.